Table1_Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier.DOCX
Background:TGFB3 variants cause Loeys–Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection. The exact disease phenotype is hard to delineate because of few identified cases and highly variable clinical representation. Methodology: We provide the results of a haplotype analysis and a medical record review of clinical features of 27 individuals from 5 different families, originating from the Campine region in Flanders, carrying the NM_003239.5(TGFB3):c.787G>C p.(Asp263His) likely pathogenic variant, dbSNP:rs796051886, ClinVar:203492. The Asp 263 residue is essent... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Dataset |
Erscheinungsdatum: | 2023 |
Schlagwörter: | Genetics / Genetic Engineering / Biomarkers / Developmental Genetics (incl. Sex Determination) / Epigenetics (incl. Genome Methylation and Epigenomics) / Gene Expression (incl. Microarray and other genome-wide approaches) / Genome Structure and Regulation / Genomics / Genetically Modified Animals / Livestock Cloning / Gene and Molecular Therapy / Loeys–Dietz syndrome (LDS) / TGFB3 / thoracic aortic aneurysm and dissection (TAAD) / founder / genetic modifiers / connective tissue disorder / variable expressivity |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-26511700 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.3389/fgene.2023.1251675.s001 |